These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9023707)
1. High blood pressure and end-organ damage. Cutler JA J Hypertens Suppl; 1996 Dec; 14(6):S3-6. PubMed ID: 9023707 [TBL] [Abstract][Full Text] [Related]
2. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. He J; Whelton PK J Hypertens Suppl; 1999 Jun; 17(2):S7-13. PubMed ID: 10465061 [TBL] [Abstract][Full Text] [Related]
3. [Hypertension as a function of age]. Gensini GF; Corradi F Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125 [TBL] [Abstract][Full Text] [Related]
4. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S; Bakir SE Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856 [TBL] [Abstract][Full Text] [Related]
5. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138 [TBL] [Abstract][Full Text] [Related]
6. Blood pressure and coronary heart disease: a review of the evidence. Lawes CM; Bennett DA; Lewington S; Rodgers A Semin Vasc Med; 2002 Nov; 2(4):355-68. PubMed ID: 16222626 [TBL] [Abstract][Full Text] [Related]
7. The paradigm has shifted to systolic blood pressure. Black HR J Hum Hypertens; 2004 Dec; 18 Suppl 2():S3-7. PubMed ID: 15592571 [TBL] [Abstract][Full Text] [Related]
8. Left ventricular hypertrophy and heart failure in women. Agabiti-Rosei E; Muiesan ML J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849 [TBL] [Abstract][Full Text] [Related]
9. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades. Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553 [TBL] [Abstract][Full Text] [Related]
11. The role of systolic blood pressure in determining risk for cardiovascular disease. Levy D J Hypertens Suppl; 1999 Feb; 17(1):S15-8. PubMed ID: 10340839 [TBL] [Abstract][Full Text] [Related]
12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
13. Is systolic pressure a better target for antihypertensive treatment than diastolic pressure? Leonetti G; Cuspidi C; Facchini M; Stramba-Badiale M J Hypertens Suppl; 2000 Jul; 18(3):S13-20. PubMed ID: 10952083 [TBL] [Abstract][Full Text] [Related]
14. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome. Leenen FH Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209 [TBL] [Abstract][Full Text] [Related]
16. New treatment guidelines for a patient with diabetes and hypertension. Mogensen CE J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164 [TBL] [Abstract][Full Text] [Related]
17. The Hypertension Optimal Treatment study and the importance of lowering blood pressure. Hansson L J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study. Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468 [TBL] [Abstract][Full Text] [Related]